Diabetes in Asia
Diabetes in Asia
复制标题
DOI：
10.1016/s0140-6736(10)60435-7
复制
发表时间：
2010-03
期刊：
影响因子：
--
通讯作者：
Vishal Sharma;V. Kumar
中科院分区：
文献类型：
--
作者：
Vishal Sharma;V. Kumar
亚洲糖尿病问题研讨会是及时的。1亚洲糖尿病患者人数的不断增长可能会给这些发展中经济体带来重大的管理问题。然而，糖尿病发病率的上升也可能对已经猖獗的传染病，特别是结核病产生影响。众所周知，糖尿病会增加患结核病的风险，因为它会增加潜伏感染转化为活动性疾病的机会。2糖尿病的存在可导致结核病对常规治疗的反应减弱，此类患者的死亡率可能更高。3一些研究指出，糖尿病患者患耐多药结核病的风险增加。4糖尿病还可能增加结核病阳性的可能性，从而增加传染性。5亚洲糖尿病的流行将导致这些发展中经济体结核病管理费用的增加。尽管全球结核病发病率正在稳定，但糖尿病患者人数的增加可能会阻碍亚洲实现千年发展目标。
The Seminar on diabetes in Asia was timely. 1 The ever-burgeoning population of diabetic patients in Asia is likely to create major management issues in these developing economies. Yet the rising prevalence of diabetes is also likely to have an effect on the already rampant communicable diseases, especially tuberculosis. Diabetes is known to increase the risk of acquiring tuberculosis since it can increase conversion of latent infection into active disease. 2 The presence of diabetes can result in a diminished response of tuberculosis to usual therapy, and mortality rates in such patients may be higher. 3 Some studies have noted an increased risk of multidrugresistant tuberculosis in patients with diabetes. 4 Diabetes is also likely to increase the possibility of sputumpositive tuberculosis, thereby increasing infectivity. 5 The epidemic of diabetes in Asia will result in an escalation in the cost of management of tuberculosis in these developing economies. Although the incidence of tuberculosis is stabilising globally, the increasing population of diabetics may hamper achievement of the Millennium Development Goals in Asia.